Potential favorable action of sodium-glucose cotransporter-2 inhibitors on sudden cardiac death: a brief overview

The primary pharmacological action of sodium-glucose co-transporter 2 (SGLT2) inhibitors is to inhibit the reabsorption of glucose and sodium ions from the proximal tubules of the kidney and to promote urinary glucose excretion. Notably, several clinical trials have recently demonstrated potent prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Tatsuya, Kouzu, Hidemichi, Yano, Toshiyuki, Sakuma, Ichiro, Furuhashi, Masato, Tohse, Noritsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214280/
https://www.ncbi.nlm.nih.gov/pubmed/37252114
http://dx.doi.org/10.3389/fcvm.2023.1159953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214280/
https://www.ncbi.nlm.nih.gov/pubmed/37252114
http://dx.doi.org/10.3389/fcvm.2023.1159953

Ejemplares similares